240 related articles for article (PubMed ID: 27835661)
1. Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea.
Yang MS; Lee JY; Kim J; Kim GW; Kim BK; Kim JY; Park HW; Cho SH; Min KU; Kang HR
PLoS One; 2016; 11(11):e0165933. PubMed ID: 27835661
[TBL] [Abstract][Full Text] [Related]
2. Incidence of toxic epidermal necrolysis and Stevens-Johnson Syndrome in an HIV cohort: an observational, retrospective case series study.
Mittmann N; Knowles SR; Koo M; Shear NH; Rachlis A; Rourke SB
Am J Clin Dermatol; 2012 Feb; 13(1):49-54. PubMed ID: 22145749
[TBL] [Abstract][Full Text] [Related]
3. Identification of Stevens-Johnson syndrome and toxic epidermal necrolysis in electronic health record databases.
Davis RL; Gallagher MA; Asgari MM; Eide MJ; Margolis DJ; Macy E; Burmester JK; Selvam N; Boscarino JA; Cromwell LF; Feigelson HS; Kuntz JL; Pawloski PA; Penfold RB; Raebel MA; Sridhar G; Wu A; La Grenade LA; Pacanowski MA; Pinheiro SP
Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):684-92. PubMed ID: 25914229
[TBL] [Abstract][Full Text] [Related]
4. Risk of toxic epidermal necrolysis and Stevens-Johnson syndrome associated with benzodiazepines: a population-based cohort study.
Martín-Merino E; de Abajo FJ; Gil M
Eur J Clin Pharmacol; 2015 Jun; 71(6):759-766. PubMed ID: 25939709
[TBL] [Abstract][Full Text] [Related]
5. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.
Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L;
Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641
[TBL] [Abstract][Full Text] [Related]
6. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients.
Chan HL; Stern RS; Arndt KA; Langlois J; Jick SS; Jick H; Walker AM
Arch Dermatol; 1990 Jan; 126(1):43-7. PubMed ID: 2404462
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study.
Barvaliya M; Sanmukhani J; Patel T; Paliwal N; Shah H; Tripathi C
J Postgrad Med; 2011; 57(2):115-9. PubMed ID: 21654132
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
[TBL] [Abstract][Full Text] [Related]
9. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.
Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G
Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222
[TBL] [Abstract][Full Text] [Related]
10. Examining triage patterns of inhalation injury and toxic epidermal necrolysis-Stevens Johnson syndrome.
Davis JS; Pandya RK; Pizano LR; Namias N; Dearwater S; Schulman CI
J Burn Care Res; 2013; 34(5):492-7. PubMed ID: 23966120
[TBL] [Abstract][Full Text] [Related]
11. Lifetime risk, life expectancy, loss-of-life expectancy and lifetime healthcare expenditure for Stevens-Johnson syndrome/toxic epidermal necrolysis in Taiwan: follow-up of a nationwide cohort from 2008 to 2019.
Chiu YM; Chiu HY
Br J Dermatol; 2023 Oct; 189(5):553-560. PubMed ID: 37427802
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006.
Yamane Y; Aihara M; Ikezawa Z
Allergol Int; 2007 Dec; 56(4):419-25. PubMed ID: 17713361
[TBL] [Abstract][Full Text] [Related]
13. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R
Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
[TBL] [Abstract][Full Text] [Related]
14. [Stevens-Johnson syndrome and toxic epidermal necrolysis in a teaching hospital in Lomé, Togo: retrospective study of 89 cases].
Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Tchangaï-Walla K; Pitché P
Med Trop (Mars); 2010 Jun; 70(3):255-8. PubMed ID: 20734593
[TBL] [Abstract][Full Text] [Related]
15. Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany.
Schöpf E; Stühmer A; Rzany B; Victor N; Zentgraf R; Kapp JF
Arch Dermatol; 1991 Jun; 127(6):839-42. PubMed ID: 2036029
[TBL] [Abstract][Full Text] [Related]
16. Stevens-Johnson syndrome and toxic epidermal necrolysis in Hong Kong.
Cheung CMT; Chang MM; Li JJX; Chan AWS
Hong Kong Med J; 2024 Apr; 30(2):102-109. PubMed ID: 38531617
[TBL] [Abstract][Full Text] [Related]
17. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
Tan SK; Tay YK
Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
[TBL] [Abstract][Full Text] [Related]
18. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
[TBL] [Abstract][Full Text] [Related]
19. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience.
Forman R; Koren G; Shear NH
Drug Saf; 2002; 25(13):965-72. PubMed ID: 12381216
[TBL] [Abstract][Full Text] [Related]
20. Stevens-Johnson syndrome and toxic epidermal necrolysis: a 20-year single-center experience.
Lalosevic J; Nikolic M; Gajic-Veljic M; Skiljevic D; Medenica L
Int J Dermatol; 2015 Aug; 54(8):978-84. PubMed ID: 25385069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
